A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo.

A B Shanafelt; Y Lin; M C Shanafelt; C P Forte; N Dubois-Stringfellow; C Carter; J A Gibbons; S L Cheng; K A Delaria; R Fleischer

doi:10.1038/81199

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo.

Identifier:nobleid.org/w1/20260515/94BADEB7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/94BADEB7.svg?ark=w1%2F20260515%2F94BADEB7)](https://nobleid.org/work/w1/20260515/94BADEB7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

N Dubois-Stringfellow

Claim authorship of this work

A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo.

Identifier:nobleid.org/w1/20260515/94BADEB7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/94BADEB7.svg?ark=w1%2F20260515%2F94BADEB7)](https://nobleid.org/work/w1/20260515/94BADEB7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

N Dubois-Stringfellow

Claim authorship of this work